You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

REBLOZYL

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Minimisation Measures for REBLOZYL Among Healthcare

Active, not recruiting
  • Myelodysplastic Syndromes
  • Beta-thalassemia
    • City, State, Austria
      Local Institution
    Aug 4, 2022

    Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

    Not yet recruiting
    • Myelodysplastic Syndrome
    • Beta Thalassemia
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    MDS Trial in United States (Lenalidomide, Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Miami, Florida
    • +5 more
    Sep 28, 2022

    Anemia Trial in Worldwide (biological, drug, other)

    Recruiting
    • Anemia
    • Luspatercept
    • +2 more
    • Halifax, Nova Scotia, Canada
    • +11 more
    Jan 3, 2023

    MDS Trial in Germany (Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Hamburg, Germany
    • +4 more
    Dec 20, 2021

    MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

    Recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Luspatercept Injection [Reblozyl]
    • Alessandria, Italy
    • +22 more
    Jun 20, 2023

    MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

    Recruiting
    • MDS
    • Myelodysplastic Syndromes
    • Luspatercept Injection [Reblozyl]
    • Eprex
    • Amiens, France
    • +30 more
    May 19, 2022

    MDS Trial in Worldwide (Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Los Alamitos, California
    • +53 more
    Sep 13, 2023

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022